Trump’s Lilly-Novo deal; Metsera takeover bids are raised; FDA releases second round of national priority vouchers. President Donald Trump struck a deal with Eli Lilly and Novo Nordisk to lower the ...

Small-business owners and their employees are worried about their health care and their livelihoods as insurance prices surge.

More than two dozen Democrats in the House are pressing the Trump administration to reverse a new policy that makes it harder for male veterans with breast cancer to get health coverage.

The new reporting segment comprises PR and public affairs firms Allison, Hunter, Consulum, HarrisX, SKDK, Sloane & Company and Targeted Victory.

President Donald Trump’s push to eliminate a federal disaster preparedness program threatens a fund used by state health systems from Republican-led Texas to the Democratic stronghold of California.

Recursion announced Najat Khan, PhD, currently chief R&D and commercial officer and a board member, will succeed co-founder and CEO Chris Gibson, PhD as CEO and president. Khan will also continue in ...

Trump to announce Lilly, Novo drug pricing deals; FDA approved a pricey drug over reviewer concerns; Novo’s new obesity pill.

To read yesterday’s edition of Five things for pharma marketers to know, click here.

Metsera-Pfizer-Novo updates; Why the FDA drug chief resigned; The “big flaw” in Big Pharma’s patient advocacy.

As part of national settlements, more than a dozen companies that sold prescription painkillers are expected to pay state and local governments upward of $50 billion over nearly two decades.

A large study from Massachusetts has found that babies whose mothers had COVID-19 while pregnant were slightly more likely to have a range of neurodevelopmental diagnoses by age 3.

Shame is a common and highly uncomfortable human emotion. Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more. In a world where healthcare ...